Biotechnology has the power to improve human health, address environmental challenges and change the way the world does business, according to a new Organization for Economic Cooperation and Development report, The Bioeconomy to 2030: Designing a Policy Agenda, examines the role of biotechnology in the global economy over the next two decades and outlines policies that could maximize its benefits.
Already biotech-based drugs provide greater health advantages than their traditional counterparts. By 2015 virtually all new drugs, about half of global production of the world's major crops and an increasing number of everyday products (eg, food additives, plastics, fuels and detergents) will be produced using biotechnology. New crop varieties under development could increase global food production while requiring less water, pesticides and fertilizers.
Biotech could produce 2.7% of GDP by 2030
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze